Thus, this study aims to evaluate circulating LPL, LPA and MAG levels in different rat models of CVD, i.e., hypertension (HTN), heart failure (HF) and pulmonary hypertension (PH) in order to provide new insights to the interest of targeting LPA metabolism with pharmacological compounds. The gene discussed is LPL; the disease is Hypertension.